Does Anaerostipes hadrus correlate to cancer?
Pro Research Analysisby 
Searched over 200M research papers
Correlation Between Anaerostipes hadrus and Cancer
Introduction to Anaerostipes hadrus and Cancer
Anaerostipes hadrus is a butyrate-producing bacterium found in the human gut microbiota. Recent studies have explored its potential role in various types of cancer, including esophageal, pancreatic, and colorectal cancers. This article synthesizes the findings from multiple research papers to understand the correlation between Anaerostipes hadrus and cancer.
Anaerostipes hadrus and Esophageal Cancer
In a study investigating the effects of synbiotics on adverse events during neoadjuvant chemotherapy (NAC) in esophageal cancer patients, Anaerostipes hadrus was found to be significantly more abundant in patients who did not experience severe adverse events such as febrile neutropenia (FN) and severe diarrhea . The presence of A. hadrus was associated with higher intestinal concentrations of beneficial short-chain fatty acids like acetic acid and butyric acid, which are known to have anti-inflammatory properties . This suggests that A. hadrus may help mitigate some of the adverse effects of chemotherapy in esophageal cancer patients.
Anaerostipes hadrus and Pancreatic Cancer
Research on the gut microbiota of pancreatic cancer patients revealed a significant decrease in the abundance of Anaerostipes hadrus compared to healthy controls . The study highlighted that butyrate-producing bacteria, including A. hadrus, were significantly less prevalent in pancreatic cancer patients. This reduction in butyrate-producing bacteria was negatively correlated with the neutrophil-to-lymphocyte ratio, a marker often associated with inflammation and poor prognosis in cancer patients . These findings suggest that a lower abundance of A. hadrus may be linked to the progression and poor outcomes in pancreatic cancer.
Anaerostipes hadrus and Colorectal Cancer
A study focusing on the gut microbiome's role in colorectal cancer (CRC) found that Anaerostipes hadrus was more abundant in healthy controls compared to patients with colorectal adenoma (AD) and CRC . The presence of A. hadrus, along with other butyrate-producing bacteria, was associated with a lower risk of CRC, indicating a potential preventative role . The study also noted that the abundance of these beneficial bacteria decreased as the disease progressed from adenoma to carcinoma, suggesting that maintaining a healthy gut microbiota could be crucial in preventing CRC.
Conclusion
The current body of research indicates a significant correlation between Anaerostipes hadrus and various types of cancer. Higher levels of A. hadrus are associated with reduced adverse events in esophageal cancer patients undergoing chemotherapy, a lower incidence of pancreatic cancer, and a preventative role in colorectal cancer. These findings underscore the potential of A. hadrus as a beneficial component of the gut microbiota in mitigating cancer progression and improving patient outcomes. Further research is needed to explore the mechanisms through which A. hadrus exerts its protective effects and to develop targeted therapies that can modulate its abundance in the gut.
Sources and full results
Most relevant research papers on this topic